2020 Revenues ($USD) : $2,354,911,934
2020 Revenues (foreign currencies) : ₹174,600,000,000
2020 R&D spend : $152,988,351
2020 Number of Employees : 21,000
Fiscal Year End : 3/31/2020
Key People : K. Satish Reddy, chair

The late scientist and entrepreneur K. Anji Reddy started the Indian multinational in 1984 to make medicines accessible to everyone. The company's global generics business crossed the $1 billion mark in 2015. These days, the company offers more than 400 generic drugs and touts itself as one of the world's largest makers of active pharmaceuticals ingredients. The company is playing an important role in the fight against COVID-19 in India as it collaborates with the Russian Direct Investment Fund to conduct clinical trials and supply 100 million doses of Russia's Sputnik V vaccine to the South Asian giant. –CN